Differential involvement of μ1-opioid receptors in dermorphin tetrapeptide analogues-induced antinociception

European Journal of Pharmacology

Volumn 486, Issue 1, 2004, Pages 19-24

  Mizoguchi, Hirokazu ^a   Yuhki, Masayuki ^a   Watanabe, Hiroyuki ^a   Hayashi, Takafumi ^a   Sakurada, Chikai ^b   Yonezawa, Akihiko ^a   Sakurada, Tsukasa ^b   Sakurada, Shinobu ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^b DAIICHI UNIVERSITY OF PHARMACY   (Japan)

Author keywords

Antinociception; Dermorphin; Mouse; Naloxonazine; Tetrapeptide; Opioid receptor

Indexed keywords

DERMORPHIN DERIVATIVE; FORMALDEHYDE; MU OPIATE RECEPTOR; NALOXONE; PEPTIDE DERIVATIVE; TYROSYL DEXTRO ARGINYLPHENYLALANYL BETA ALANINAMIDE; TYROSYL DEXTRO ARGINYLPHENYLALANYL BETA ALANINE; UNCLASSIFIED DRUG;

AMIDATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; EXPERIMENTAL TEST; MALE; MOUSE; NONHUMAN; PAIN; PRIORITY JOURNAL;

EID: 1642523079     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2003.12.007     Document Type: Article

References (23)

1. Broccardo M., Erspamer V., Falconieri Erspamer G., Importa G., Linari P., Melchiorri P., Montecucchi P.C. Pharmacological data on dermorphins, a new class of potent opioid peptides from amphibian skin. Br. J. Pharmacol. 73:1981;625-631.
2. 2]-dermorphin tetrapeptide analogs and morphine in mice. Pharmacol. Biochem. Behav. 31:1988;439-444.
3. Chaki K., Sakurada S., Sakurada T., Kisara K., Suzuki K. N-terminal tetrapeptide of dermorphin and D-Arg-substituted tetrapeptides: inactivation process of the antinociceptive activity by peptidase. Life Sci. 46:1990;1671-1678.
4. Elliott J., Smart D., Lambert D.G., Traynor J.R. Characterization of μ-opioid receptors on SH-SY5Y cells using naloxonazine and β-funaltrexamine. Eur. J. Pharmacol., Mol. Pharmacol. Sect. 268:1994;447-450.
5. Haley M.J., McCormick W.G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mice. Br. J. Pharmacol. 12:1957;12-15.
6. Heyman J.S., Williams C.L., Burks T.F., Mosberg H.I., Porreca F. Dissociation of opioid antinociception and central gastrointestinal propulsion in the mouse: studies with naloxonazine. J. Pharmacol. Exp. Ther. 245:1988;238-243.
7. Hylden J.L.K., Wilcox G.L. Intrathecal morphine in mice: a new technique. Eur. J. Pharmacol. 167:1980;313-316.
8. Krumins S. Characterization of dermorphin bindings to membranes of rat brain and heart. Neuropeptides. 9:1987;93-102.
9. Montecucchi P.C., de Castiglione R., Piani S., Gozzini L., Erspamer V. Amino acid composition and sequence of dermorphin, a novel opiate-like peptide from the skin of Phyllomedusa sauvagei. Int. J. Pept. Protein Res. 17:1981;275-283.
10. Negri L., Improta G. Distribution and metabolism of dermorphin in rats. Pharmacol. Res. Commun. 16:1984;1183-1194.
11. 1 sites. Mol. Pharmacol. 25:1984;29-37.
12. Pasternak G.W. Pharmacological mechanisms of opioid analgesics. Clin. Neuropharmacol. 16:1993;1-18.
13. Pasternak G.W., Wood P.J. Multiple mu opiate receptors. Life Sci. 38:1986;1889-1898.
14. Pasternak G.W., Childers S.R., Snyder S.H. Naloxazone, a long-acting opiate antagonist: effects on analgesia in intact animals and on opiate receptor binding in vitro. J. Pharmacol. Exp. Ther. 214:1980;455-462.
15. Sakurada S., Watanabe T., Sakurada T., Ando R., Kisara K., Sasaki Y., Suzuki K. Potentiation of dermorphin-induced antinociception by peptidase inhibitors. J. Pharm. Pharmacol. 38:1986;230-232.
16. Sakurada S., Zadina J.E., Kastin A.J., Katsuyama S., Fujimura T., Murayama K., Yuki M., Ueda H., Sakurada T. Differential involvement of μ-opioid receptor subtypes in endomorphin-1- and -2-induced antinociception. Eur. J. Pharmacol. 372:1999;25-30.
17. Sakurada S., Hayashi T., Yuhki M., Fujimura T., Murayama K., Yonezawa A., Sakurada C., Takeshita M., Zadina J.E., Kastin A.J., Sakurada T. Differential antagonism of endomorphin-1 and endomorphin-2 spinal antinociception by naloxonazine and 3-methoxynaltrexone. Brain Res. 881:2000;1-8.
18. Salvadori S., Sarto G., Tomatis R. Synthesis and pharmacological activity of dermorphin and its N-terminal sequence. Int. J. Protein Res. 19:1982;536-542.
19. 2-dermorphin tetrapeptide analogs: a potent and long-lasting analgesic activity after subcutaneous administration. Biochem. Biophys. Res. Commun. 120:1984;214-218.
20. 2 and its fluorinate aromatic amino acid derivatives. Chem. Pharm. Bull. 39:1991;2316-2318.
21. Sato T., Sakurada S., Sakurada T., Kisara K., Sasaki Y., Suzuki K. A comparison of the antinociceptive and behavioral effects of D-Arg substituted dipeptides and tetrapeptides in mice. Peptides. 6:1985;35-40.
22. 1-opioid receptors to morphine-induced antinociception. Eur. J. Pharmacol. 369:1999;183-187.
23. Wolozin B.L., Pasternak G.W. Classification of multiple morphine and enkephalin binding sites in the central nervous system. Proc. Natl. Acad. Sci. U. S. A. 78:1981;6181-6185.